Inhibition of adenosine 3',5'-cyclic monophosphate phosphodiesterase.

PubWeight™: 0.80‹?›

🔗 View Article (PMC 1179712)

Published in Biochem J on December 01, 1970

Authors

J B Smith, D C Mills

Articles by these authors

Nuclear dna amounts in angiosperms. Philos Trans R Soc Lond B Biol Sci (1976) 10.59

Antibody formation by single cells from lymph nodes and efferent lymph of sheep. J Exp Med (1966) 8.86

Aspirin selectively inhibits prostaglandin production in human platelets. Nat New Biol (1971) 7.75

Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Engl J Med (1998) 4.08

Genome size and the proportion of repeated nucleotide sequence DNA in plants. Biochem Genet (1974) 3.66

Metabolism of [14C]arachidonic acid by human platelets. Biochim Biophys Acta (1976) 2.61

Quantitation of dihydropyrimidine dehydrogenase expression by real-time reverse transcription polymerase chain reaction. Anal Biochem (2000) 2.53

Effects of adrenaline on human blood platelets. J Physiol (1967) 2.38

Prostaglandin D2 inhibits the aggregation of human platelets. Thromb Res (1974) 2.35

Serum stimulates the Na+,K+ pump in quiescent fibroblasts by increasing Na+ entry. Proc Natl Acad Sci U S A (1978) 2.29

The traffic of cells through tissues: a study of peripheral lymph in sheep. J Anat (1970) 2.24

The major in vivo modifications of the human water-insoluble lens crystallins are disulfide bonds, deamidation, methionine oxidation and backbone cleavage. Exp Eye Res (2000) 2.10

Japanese yew poisoning of large domestic animals in the Midwest. J Am Vet Med Assoc (1977) 2.07

Perirenal edema and toxic nephrosis in cattle, associated with ingestion of pigweed. J Am Vet Med Assoc (1975) 2.04

The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3':5'-cyclic monophosphate in platelets. Biochem J (1971) 2.04

The release of nucleotides, 5-hydroxytryptamine and enzymes from human blood platelets during aggregation. J Physiol (1968) 1.97

Formation of prostaglandins during the aggregation of human blood platelets. J Clin Invest (1973) 1.96

Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets. J Biol Chem (1998) 1.93

The migration of cells through chronically inflamed tissues. J Pathol (1970) 1.92

Arachidonic acid causes sudden death in rabbits. Science (1974) 1.91

Activation of suppressor T cells in human autologous mixed lymphocyte culture. J Immunol (1979) 1.90

Age-related changes in human lens crystallins identified by two-dimensional electrophoresis and mass spectrometry. Exp Eye Res (1998) 1.88

The effects of ATP on platelets: evidence against the central role of released ADP in primary aggregation. Blood (1975) 1.87

Malondialdehyde formation as an indicator of prostaglandin production by human platelets. J Lab Clin Med (1976) 1.86

Sequence analysis of betaA3, betaB3, and betaA4 crystallins completes the identification of the major proteins in young human lens. J Biol Chem (1997) 1.84

Selective release of archidonic acid from the phospholipids of human platelets in response to thrombin. J Clin Invest (1977) 1.84

Reevaluation of ampicillin therapy for Hemophilus influenzae meningitis. An appraisal based on a review of cases of persistent or recurrent infection. Am J Dis Child (1971) 1.82

Life-threatening toxicity in a dihydropyrimidine dehydrogenase-deficient patient after treatment with topical 5-fluorouracil. Clin Cancer Res (1999) 1.82

Formation of an intermediate in prostaglandin biosynthesis and its association with the platelet release reaction. J Clin Invest (1974) 1.76

Arachidonic acid-induced human platelet aggregation and prostaglandin formation. Prostaglandins (1973) 1.69

The murine neutrophil-chemoattractant chemokines LIX, KC, and MIP-2 have distinct induction kinetics, tissue distributions, and tissue-specific sensitivities to glucocorticoid regulation in endotoxemia. J Leukoc Biol (1998) 1.67

Syngeneic mixed lymphocyte reaction in mice: strain distribution, kinetics, participating cells, and absence in NZB mice. J Immunol (1978) 1.67

Ischemia-reperfusion of rat myocardium activates nuclear factor-KappaB and induces neutrophil infiltration via lipopolysaccharide-induced CXC chemokine. Circulation (2001) 1.63

Prostacyclin: a potentially valuable agent for preserving myocardial tissue in acute myocardial ischemia. Science (1978) 1.62

Formation and release of prostaglandins by platelets in response to thrombin. Br J Pharmacol (1970) 1.59

Carbodiimide-resistant membrane adenosine triphosphatase in mutants of Streptococcus faecalis. I. Studies of the mechanism of resistance. J Biol Chem (1972) 1.58

Bovine endothelial cells in culture produce thromboxane as well as prostacyclin. J Clin Invest (1981) 1.58

Thromboxane release during pacing-induced angina pectoris: possible vasoconstrictor influence on the coronary vasculature. Circulation (1980) 1.56

Metabolism and function of human platelets washed by albumin density gradient separation. Br J Haematol (1977) 1.56

Age-related changes in human lens crystallins identified by HPLC and mass spectrometry. Exp Eye Res (1998) 1.53

Post-translational modifications of water-soluble human lens crystallins from young adults. J Biol Chem (1994) 1.53

Dissociation of vasoconstrictor and platelet aggregatory activities of thromboxane by carbocyclic thromboxane A2, a stable analog of thromboxane A2. Proc Natl Acad Sci U S A (1980) 1.52

Bryostatin, an activator of the calcium phospholipid-dependent protein kinase, blocks phorbol ester-induced differentiation of human promyelocytic leukemia cells HL-60. Proc Natl Acad Sci U S A (1986) 1.51

Purification of membrane attachment and inhibitory subunits of the proton translocating adenosine triphosphatase from Escherichia coli. Biochemistry (1977) 1.49

Studies on the protective effect of prostacyclin in acute myocardial ischemia. Eur J Pharmacol (1979) 1.47

Synthesis and biological properties of pinane-thromboxane A2, a selective inhibitor of coronary artery constriction, platelet aggregation, and thromboxane formation. Proc Natl Acad Sci U S A (1979) 1.47

Selective binding site for [3H]prostacyclin on platelets. J Clin Invest (1979) 1.47

Identification of possible regions of chaperone activity in lens alpha-crystallin. Exp Eye Res (1996) 1.46

Intraintestinal toxin in infant mice challenged intragastrically with Clostridium botulinum spores. Infect Immun (1978) 1.42

Inhibition of prostacyclin by treatment of endothelium with aspirin. Correlation with platelet adherence. J Clin Invest (1979) 1.39

Duration of inhibition of platelet prostaglandin formation and aggregation by ingested aspirin or indomethacin. Prostaglandins (1973) 1.39

Stress and developmental regulation of the yeast C-type cyclin Ume3p (Srb11p/Ssn8p). EMBO J (1997) 1.35

Human blood prostaglandins: formation during clotting. Prostaglandins (1972) 1.35

Formation of lysophosphatidylcholine by human platelets in response to thrombin. Support for the phospholipase A2 pathway for the liberation of arachidonic acid. J Biol Chem (1981) 1.34

Immunologic studies in chronic lymphocytic leukemia: defective stimulation of T-cell proliferation in autologous mixed lymphocyte culture. J Natl Cancer Inst (1977) 1.34

Stimulation of autologous and allogeneic human T cells by B cells occurs through separate B-cell antigen systems. Cell Immunol (1978) 1.33

Deamidation and disulfide bonding in human lens gamma-crystallins. Exp Eye Res (1998) 1.31

Temperature and nucleotide dependence of calcium release by myo-inositol 1,4,5-trisphosphate in cultured vascular smooth muscle cells. J Biol Chem (1985) 1.30

Modifications of the water-insoluble human lens alpha-crystallins. Exp Eye Res (1996) 1.30

Cytogenetics of fetal abortions. Pediatrics (1967) 1.29

Stimulation of human platelet adenylate cyclase by prostaglandin D2. Thromb Res (1974) 1.26

Size of human lens beta-crystallin aggregates are distinguished by N-terminal truncation of betaB1. J Biol Chem (1997) 1.25

The role of the lymphatic system and lymphoid cells in the establishment of immunological memory. Aust J Exp Biol Med Sci (1970) 1.24

Blood platelet nucleotides in man and other species. Nature (1969) 1.24

Inhibition of aggregation and stimulation of cyclic AMP generation in intact human platelets by the diterpene forskolin. Mol Pharmacol (1982) 1.23

Use of a radioimmunoassay to study thrombin-induced release of PGI2 from cultured endothelium. Thromb Res (1979) 1.22

Malignant peripheral nerve sheath tumor (malignant schwannoma) of urinary bladder in von Recklinghausen neurofibromatosis. Urology (1991) 1.20

Viral hepatitis, postnecrotic cirrhosis, and hepatocellular carcinoma. Lancet (1969) 1.20

Detection and determination of adenosine diphosphate and related substances in plasma. Biochem J (1966) 1.20

Anticardiolipin antibodies in patients with rheumatic diseases. Arthritis Rheum (1987) 1.19

Ubiquitination of protein kinase C-alpha and degradation by the proteasome. J Biol Chem (1996) 1.19

The response of the popliteal lymph node of the sheep to swine influenza virus. Aust J Exp Biol Med Sci (1970) 1.18

Lithium transport by fibroblastic mouse cells: characterization and stimulation by serum and growth factors in quiescent cultures. J Cell Physiol (1978) 1.17

The platelet defect associated with albumism. Br J Haematol (1972) 1.17

The sequence of human betaB1-crystallin cDNA allows mass spectrometric detection of betaB1 protein missing portions of its N-terminal extension. J Biol Chem (1996) 1.17

Hereditary giant platelet syndrome. Absence of collagen-induced coagulant activity and deficiency of factor-XI binding to platelets. Br J Haematol (1975) 1.16

Activation of atypical protein kinase C zeta by caspase processing and degradation by the ubiquitin-proteasome system. J Biol Chem (2000) 1.15

Analysis of angiotensin-stimulated sodium transport in cultured smooth muscle cells from rat aorta. J Cell Physiol (1983) 1.15

Antibodies to phospholipids and nuclear antigens in patients with repeated abortions. Am J Obstet Gynecol (1986) 1.15

Angiotensin II rapidly increases phosphatidate-phosphoinositide synthesis and phosphoinositide hydrolysis and mobilizes intracellular calcium in cultured arterial muscle cells. Proc Natl Acad Sci U S A (1984) 1.14

Cathepsin G is a strong platelet agonist released by neutrophils. Biochem J (1988) 1.14

Human lymphocyte responses are enhanced by culture at 40 degrees C. J Immunol (1978) 1.13

In vivo carbamylation and acetylation of water-soluble human lens alphaB-crystallin lysine 92. Protein Sci (2001) 1.13

Bryostatins: potent, new mitogens that mimic phorbol ester tumor promoters. Biochem Biophys Res Commun (1985) 1.13

Detection of thromboxane B2 in peripheral blood of patients with Prinzmetal's angina. Prostaglandins Med (1979) 1.11

Leptomeningeal carcinomatosis: a sequela of cholangiocarcinoma. Am Surg (1997) 1.11

Hordeum and Secale mitotic genomes lie apart in a hybrid. J Cell Sci (1981) 1.11

Antibodies which antagonise the effects of prostacyclin. Nature (1978) 1.10

Oligomerization and phase separation in globular protein solutions. Biophys Chem (1998) 1.10

Evidence for a role for tyrosine phosphorylation of phospholipase C gamma 2 in collagen-induced platelet cytosolic calcium mobilization. Biochem J (1994) 1.10

Characterization of the inhibitory (epsilon) subunit of the proton-translocating adenosine triphosphatase from Escherichia coli. Biochemistry (1980) 1.09

Platelets and the vessel wall: how much aspirin? Lancet (1980) 1.09

The adenylate kinase of human plasma, erythrocytes and platelets in relation to the degradation of adenosine diphosphate in plasma. Biochem J (1967) 1.09

Bryostatin 1 and phorbol ester down-modulate protein kinase C-alpha and -epsilon via the ubiquitin/proteasome pathway in human fibroblasts. Mol Pharmacol (1997) 1.09

Two temporal parameters of food postponement. J Exp Anal Behav (1972) 1.08

Formation and metabolism of inositol 1,4,5-trisphosphate in human platelets. Biochem J (1987) 1.08

Human lens beta-crystallin solubility. J Biol Chem (2000) 1.07

2-Methylthioadenosine[beta-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets. J Clin Invest (1983) 1.07

Significance of self-recognition and interleukin-2 for immunoregulation, autoimmunity and cancer. Scand J Immunol (1982) 1.07